CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance

J Romo-Tena, D Gómez-Martín, J Alcocer-Varela - Autoimmunity reviews, 2013 - Elsevier
Abstract Cytotoxic T-Lymphocye Antigen 4 (CTLA-4) or CD152 is an inhibitory molecule that
plays a critical role in maintenance of tolerance to self-antigens. CTLA-4 is structurally as …

CD28-independent costimulation of T cells in alloimmune responses

A Yamada, K Kishimoto, VM Dong, M Sho… - The Journal of …, 2001 - journals.aai.org
T cell costimulation by B7 molecules plays an important role in the regulation of alloimmune
responses. Although both B7-1 and B7-2 bind CD28 and CTLA-4 on T cells, the role of B7-1 …

[HTML][HTML] Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses

KL Banta, X Xu, AS Chitre, A Au-Yeung, C Takahashi… - Immunity, 2022 - cell.com
Dual blockade of the PD-1 and TIGIT coinhibitory receptors on T cells shows promising early
results in cancer patients. Here, we studied the mechanisms whereby PD-1 and/or TIGIT …

Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes

Y Zhang, CJ Ma, JM Wang, XJ Ji, XY Wu… - Journal of leukocyte …, 2012 - academic.oup.com
ABSTRACT Tim-3 and PD-1 are powerful immunoinhibitory molecules involved in immune
tolerance, autoimmune responses, and antitumor or antiviral immune evasion. A current …

Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling

CE Rudd, H Schneider - Nature Reviews Immunology, 2003 - nature.com
Many studies have shown the central importance of the co-receptors CD28, inducible
costimulatory molecule (ICOS) and cytotoxic T lymphocyte antigen 4 (CTLA4) in the …

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

S Agarwal, MA Aznar, AJ Rech, CR Good, S Kuramitsu… - Immunity, 2023 - cell.com
Chimeric antigen receptor (CAR) T cell therapy targeting CD19 has achieved tremendous
success treating B cell malignancies; however, some patients fail to respond due to poor …

[HTML][HTML] LAG-3: from molecular functions to clinical applications

T Maruhashi, D Sugiura, I Okazaki… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
To prevent the destruction of tissues owing to excessive and/or inappropriate immune
responses, immune cells are under strict check by various regulatory mechanisms at …

CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition

EI Buchbinder, A Desai - American journal of clinical oncology, 2016 - journals.lww.com
The cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1)
immune checkpoints are negative regulators of T-cell immune function. Inhibition of these …

The regulation of lymphocyte activation by inhibitory receptors

PJ Leibson - Current opinion in immunology, 2004 - Elsevier
The ability of activating immune recognition receptors on lymphocytes to regulate cellular
activation and function can be profoundly altered by co-stimulation with inhibitory receptors …